History

Over the course of the last 25 years, Baylis Medical has been involved in a number of medical firsts, both in the Canadian market as well as the worldwide market.

1986

Incorporated as a Canadian Corporation by Gloria Baylis. The company introduces specialty catheters for Neuro-Embolization to the North American market. The first procedures using this new, innovative approach to treating brain aneurism are done in Quebec.

1989

Frank Baylis joins the company as the first employee after Gloria Baylis.

1990

Kris Shah joins the company – The first office at 5253 Decarie Boulevard, Montreal is opened.

1991

The Company’s import business begins to specialize in the field of Cardiac Electrophysiology. Over the course of the next decade, Baylis Medical will assist leading centers across Canada to outfit their electrophysiology labs with recording systems, RF Generators, Stimulators, EP catheters, and more.

1992

The Company introduces the King of Hearts™ Event Monitor to the Canadian market in collaboration with Instromedix; the inventors of the cardiac event monitoring.

1995

Baylis Medical begins to develop and manufacture its own line of products. The Company develops the RF Puncture system. This work is done with the assistance of world renowned physicians Dr. Benson and Dr. Nykanen at the Hospital for Sick Children’s of Toronto.  The system was commercialized in 1999 and is now recognized as the gold standard for care of this disease.

1998

Baylis Medical launches disposable RF cannula for RF ablation of spinal facet nerves

2001

Baylis Medical commercializes the world’s first computerized Pain Management RF Generator, the PMG-115. The system quickly sets a new standard in the field of chronic pain management that all subsequent systems have adopted.

2006

Baylis Medical develops the world’s first cooled-RF platform for pain management procedures. A number of therapeutic  treatments have been developed based on this platform including the  TransDiscal™ Biacuplasty system for the treatment of axial discogenic pain, the SInergy™ system for treatment of Sacroiliac joint syndrome, the ThoraCool™ system for the treatment of  Thoracic facet joint pain, and the LumbarCool™ probe for the  treatment of lumbar facet joint pain.

2008

Baylis Medical introduces the NRG™ RF Transseptal Needle. This is the first major innovation in the field of cardiac transseptal puncture in over three decades. Medical publications demonstrate that it is safer, faster, and more reliable than the old mechanical puncture needle.

2009

In June 2009, Baylis Medical acquires Fralex Therapeutics, a company developing Complex Neuro Pulse (CNP) system to treat chronic pain.

In October 2009, Kimberly-Clark* Healthcare Division acquires the Pain Management business sector from Baylis Medical which includes a number of innovative, minimally-invasive radiofrequency pain management products. The company focuses its future into the fields of Interventional Cardiology and Interventional Radiology.

2010

Baylis Medical introduces the RF PowerWire™, a radio-frequency activated guidewire used to cross chronic total occlusion in peripheral vascular structures.

2011

In September 2011, Baylis launches the OsteoCool® system for treatment of pain emanating from metastatic bone tumors.

In October 2011, Baylis Medical Executives win the Entrepreneur of the Year Award

2012

In June 2012, Baylis Medical launches the NRG®  Transseptal Needle featuring a radiopaque marker.

2013

In May 2013, Baylis Medical strengthens its US presence with a new office in Greater Boston